Literature DB >> 16087382

Where do T cells stand in rheumatoid arthritis?

Catherine Fournier1.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by destruction of cartilage and bone. The destructive lesions result from both immune responses and non-antigen-specific inflammatory processes. Little is known about the primary cause of RA. Although the primacy of T-cell-related events early in the disease remains debated, strong evidence indicates that autoantigen recognition by specific T cells is crucial to the pathophysiology of rheumatoid synovitis. We will discuss evolving concepts about T-cell involvement in RA and the roles for various T cell subsets in the development of joint abnormalities. The hypothesis that RA is a T-cell driven disease was put forward when studies of RA synovium showed numerous T cells carrying activation markers. These T cells were found to participate in the complex network of cell- and mediator-driven events leading to joint destruction. Conceivably, these T cells may be stimulated by an autoantigen (whether specific to the joints or ubiquitous), a highly conserved foreign protein cross-reacting with its human homolog, or a neo-antigen expressed as a result of posttranslational events. For many years, animal models have provided valuable evidence supporting a role for T cells in RA. We will review three murine models of arthritis caused by different mechanisms. In collagen-induced arthritis, the immune response to a joint antigen is mediated by pathogenic Th1 cells that elicit severe inflammatory synovitis. Spontaneous arthritis in K/BxN T-cell-receptor transgenic mice is related to an adaptive immune response against a ubiquitous protein whose end-stage effector mechanisms are heavily dependent on the innate immune system. In the SKG model of autoimmune inflammatory arthritis, a point mutation in the gene encoding a key signal-transduction molecule in T cells causes defective T cell selection in the thymus, which releases polyclonal autoreactive T cells. Studies in these and other animal models have established that a variety of T-cell subsets whose roles vary with cell location and disease stage can contribute to synovitis. Finally, in addition to direct autoimmune attack by effector T cells, arthritis may result from defective homeostatic control of immunity by regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087382     DOI: 10.1016/j.jbspin.2004.12.012

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  39 in total

1.  Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats.

Authors:  Venkatesan Saratha; Sorimuthu Pillai Subramanian
Journal:  Inflammopharmacology       Date:  2011-10-16       Impact factor: 4.473

2.  A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner.

Authors:  Leonard Rifas; M Neale Weitzmann
Journal:  Arthritis Rheum       Date:  2009-11

3.  CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model.

Authors:  Susanne Roser-Page; Tatyana Vikulina; Majd Zayzafoon; M Neale Weitzmann
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

4.  Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand.

Authors:  Xiaozhe Han; Xiaoping Lin; Xiaoqian Yu; Jiang Lin; Toshihisa Kawai; Karen B LaRosa; Martin A Taubman
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 5.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

6.  Engagement of activated Notch signalling in collagen II-specific T helper type 1 (Th1)- and Th17-type expansion involving Notch3 and Delta-like1.

Authors:  Z Jiao; W Wang; H Xu; S Wang; M Guo; Y Chen; J Gao
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

7.  Use of immune modulation by human adipose-derived mesenchymal stem cells to treat experimental arthritis in mice.

Authors:  Li Zhang; Xiao-Yan Wang; Peng-Jun Zhou; Zhe He; Hai-Zhao Yan; Dan-Dan Xu; Ying Wang; Wu-Yu Fu; Bi-Bo Ruan; Sheng Wang; Hai-Xuan Chen; Qiu-Ying Liu; Yu-Xia Zhang; Zhong Liu; Yi-Fei Wang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

8.  Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.

Authors:  Adrienn Angyal; Colt Egelston; Tamás Kobezda; Katalin Olasz; Anna László; Tibor T Glant; Katalin Mikecz
Journal:  Arthritis Res Ther       Date:  2010-03-18       Impact factor: 5.156

9.  Inhibitory effect of the extract of Phellodendron amurense ruprecht root on collagen-induced arthritis in mice.

Authors:  Hyo Won Jung; Kyung-Ho Kim; Yong-Ki Park
Journal:  Chin J Integr Med       Date:  2016-07-26       Impact factor: 1.978

Review 10.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.